Marybeth Rivard
Adult Health · Columbus, OHNPI 1174507487
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.2%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Gilead accounts for 93.6% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2024 at $38,559 and has fallen 98.3% since, to $647 in 2025. Among adult health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 226 payments — averaging $181.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$38K
- Viiv Healthcare Company$1K
- Johnson & Johnson$268
- Merck$210
- Lilly USA, LLC$181
- Napo Pharmaceuticals Inc$171
- plus $344 from 7 others
What the payments were for
- Consulting fees$3,7209%
- Speaking & faculty fees$22,27654%
- Travel & lodging$9,97724%
- Food & beverage$5,11512%
- Education$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 100 | $38,485 |
| Viiv Healthcare Company | 71 | $1,440 |
| Johnson & Johnson | 15 | $268 |
| Merck | 9 | $210 |
| Lilly USA, LLC | 7 | $181 |
| Napo Pharmaceuticals Inc | 6 | $171 |
| AbbVie | 6 | $118 |
| Novo Nordisk | 4 | $66 |
| Antares Pharma, Inc. | 2 | $44 |
| Theratechnologies Inc. | 2 | $40 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $28 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Exact Sciences | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$41,099 in reported general payments places this provider in the 95th percentile of 1,184 adult health providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 72 | $259,667 |
| JulucaDolutegravir/Rilpivirine | 28 | $95,570 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 23 | $87,268 |
| DovatoDolutegravir Sodium/Lamivudine | 23 | $63,363 |
| TivicayDolutegravir Sodium | 15 | $33,315 |
| PrezcobixDarunavir/Cobicistat | 13 | $31,480 |
| OzempicSemaglutide | 26 | $19,878 |
| RexultiBrexpiprazole | 16 | $16,532 |
| QuliptaAtogepant | 13 | $9,784 |
| ImvexxyEstradiol | 11 | $8,725 |
| Incruse ElliptaUmeclidinium Bromide | 12 | $4,178 |
| Estradiol Valerate | 32 | $3,241 |
| Dronabinol | 14 | $3,199 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 12 | $1,397 |
| ProgesteroneProgesterone, Micronized | 41 | $1,233 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy | $38,485 | $259,66772 claims |
| Viiv Healthcare CompanyJuluca, Dovato, Tivicay | $1,440 | $192,24866 claims |
| Johnson & JohnsonPrezcobix | $268 | $31,48013 claims |
| Novo NordiskOzempic | $66 | $19,87826 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $26 | $16,53216 claims |
| AbbVieQulipta | $118 | $9,78413 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,184 adult health providers in Ohio.
Other adult health in Columbus
- Lucretia LongColumbus$76K
- Constance Nicastro-BowmanColumbus$28K
- Michelle MormileColumbus$22K
- Kathleen MooreColumbus$17K
- Laura PopelarColumbus$17K
- James BetzColumbus$15K
- Mollie MoranColumbus$11K
- Jennifer ObrienColumbus$9K
- Karin AndersonColumbus$8K
- Megan JosephColumbus$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.